The Latest Version of the RetinaRisk App

We are excited to share with you that a new version of the RetinaRisk app is now available in the Apple Store and Google Play. Based on feedback from our users, we have redesigned the look of the app, made existing features more user-friendly and added several new features. We hope that this will make the RetinaRisk app even more valuable to our thousands of users.

Here’s a quick overview of some of the improvements in the new version and a few of the new features.

HbA1c in percentages

It is now possible to input the HbA1c values in percentages as well as mmol/mol. This is very important as the way HbA1c is displayed varies around the world.

Ease of use

Getting your diabetic retinopathy risk calculation is now easier than ever as users are invited to insert the non-modifiable risk factors (type and duration of diabetes, gender, retinopathy) up front and save the setting. This should take no longer than 30 seconds. Subsequently, the user only needs to enter the HbA1c and blood pressure values for each risk calculation.

Know your risk of diabetic eye disease

Click here to download the RetinaRisk app now!

Risk analysis

Risk analysis is one of the new features we are introducing in the updated version of the RetinaRisk app. Risk analysis tells the user which are the key risk factors impacting his/her individualized risk calculation. The key risk factors could be high blood sugar and/or blood pressure level as well as duration of diabetes.  It is hugely valuable to users to have data driven results that demonstrate which are their key risk factors and how improvement of the modifiable risk factors could significantly lower the risk of potentially blinding diabetic eye disease and expensive interventions. This empowers and motivates persons living with diabetes to become an active participant in their own wellness journey and to better understand their condition resulting in enhanced self-care.

Language options

The app is now available in three languages, English, German and Icelandic with other languages such as Spanish, French, Urdu and Arabic to follow shortly.

In the coming weeks we will be giving you more details on these and many more features that are included in the new version of the RetinaRisk app in our weekly post so stay tuned.

Similar Posts

  • Lions Club Cooperation with RetinaRisk Accelerates

    The spiraling prevalence of diabetes worldwide means that millions more people are developing complications such as diabetic retinopathy. Health practitioners and people with diabetes need to be aware of this exploding problem and the simple steps that can be taken to reduce the risk of visual impairment. Blindness from diabetic retinopathy is largely avoidable but…

  • RetinaRisk And The Diabetes Centre Sign An Agreement

    Last week, Retina Risk and The Diabetes Centre in Pakistan signed a Memorandum of Understanding outlining joint efforts to eradicate preventable vision-loss and blindness due to diabetes in Pakistan. The Diabetes Centre is a not-for-profit organization formed to serve all patients regardless of race, religion, socioeconomic status or geographic location, with the aim to alleviate…

  • What is World Diabetes Day?

    From a humble beginning in 1991 when the International Diabetes Federation celebrated the World Diabetes Day for the first time, it has become a globally celebrated event. Comprising hundreds of campaigns, activities, screenings, lectures, meetings and more, the World Diabetes Day provides an annual platform and an occasion to raise awareness about diabetes. The World…

  • |

    How To Prevent Diabetic Retinopathy?

    Diabetic retinopathy is one of the most common complications of diabetes. It’s an eye condition that affects blood vessels in the retina, the innermost layer lining the back of the inside the eye. It occurs due to damage to the small capillaries that supply blood to the light-sensitive retina at the back of the eye….

  • |

    The Importance of Individual Diabetic Retinopathy Screenings

    Personalizing screening for sight-threatening diabetic retinopathy was on the agenda at this year‘s annual meeting of the European Association for the Study of Diabetes (EASD), which was held in Barcelona, Spain in September 2019. One of our founders, Dr. Arna Guðmundsdóttir, Endocrinologist at the National Hospital in Iceland, attended the meeting and shared with us…